Clinical Trial Update: Clostridium Histolyticum Collagenase Injection for Urethral Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Clostridium histolyticum collagenase injection in urethral stricture completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Stricture

Drugs mentioned

• Clostridium histolyticum collagenase (clostridium histolyticum collagenase)

Snippet

Sponsor: University of South Florida | Conditions: Urethral Stricture | Phase 2 | Status: COMPLETED | Results posted: 2023-11-03